跳至主要内容
临床试验/NCT04174794
NCT04174794终止不适用

Investigating Reduction of aCute heArt Failure Readmission With Lung UltraSound-preliminary Trial (Pre-IcarUS)

University Hospital, Geneva1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2019年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
43
试验地点
1
主要终点
Inter-observer disagreement at admission lung ultrasound

研究概览

简要总结

In Switzerland 15% of discharged patients are readmitted within 30 days. Acute heart failure is the leading cause of hospital admission and one of the most frequent reasons for re-admission, mainly because of congestion-driven symptoms. Residual congestion is noted in 10%-15% of patients at discharge and is associated with an increased risk of re-admission and mortality. Lung ultrasound outperforms both chest X-ray and physical examination in detection of lung congestion. Several semiquantitative scanning protocols exist for quantifying congestion. The aim of this study is to compare for the first time two widely used lung ultrasound protocols, one exhaustive (28-points) and one simplified (8-points), in real-time settings. The focus is placed on reproducibility (expert-beginner interobserver concordance), feasibility (time consumption for images acquisition and interpretation) and performance (detection of B-lines clearing) of both scores. Semi-quantitative method is expected to have better feasibility with similar reproducibility and performance.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of acute heart failure on admission chart (primary or secondary diagnosis)
  • Admission from the emergency room to a general internal medicine ward
  • Presentation of acute heart failure according to European Society of Cardiology :
  • Presence of ≥1 symptom or sign based on admission chart review and
  • Raised value of N terminal-pro-brain natriuretic peptide (>300 ng/l)

排除标准

  • Interstitial lung disease, lung cancer or metastasis, acute respiratory distress syndrome, pulmonary contusion, previous lung surgery
  • Inability or unwillingness to give consent
  • Presence of oligo-anuric end stage renal disease

结局指标

主要结局

Inter-observer disagreement at admission lung ultrasound

时间窗: Day 0

The primary endpoint is the amount of disagreement between beginner and expert echographers at admission lung ultrasound. In order to compare protocols using different grading systems, a common 4-levels interstitial syndrome (IS) severity scale is defined. For the 28-point protocol, rating of total number of B-lines will be classified according to literature in severe (\>30), moderate (16-30), mild (6-15) or no signs of IS (≤5 B-lines). For the 8-point protocol, IS is arbitrarily classified as follows: 'severe' (6-8), 'moderate' (4-5), mild (2-3) and 'no signs' (0-1 positive zones).

Inter-observer disagreement at follow-up lung ultrasound

时间窗: Day 4 to 6

The amount of disagreement between beginner and expert echographers is measured at follow-up lung ultrasound. In order to compare protocols using different grading systems, a common 4-levels IS severity scale is defined. For the 28-point protocol, rating of total number of B-lines will be classified according to literature in severe (\>30), moderate (16-30), mild (6-15) or no signs of IS (≤5 B-lines). For the 8-point protocol, IS is arbitrarily classified as follows: 'severe' (6-8), 'moderate' (4-5), mild (2-3) and 'no signs' (0-1 positive zones).

次要结局

  • Time consumption for images acquisition and interpretation at follow-up lung ultrasound(Day 4 to 6)
  • Post-discharge readmission and mortality at 180 days(Day 180 post-discharge)
  • Time consumption for images acquisition and interpretation at admission lung ultrasound(Day 0)
  • Change in interstitial syndrome severity scale and amount of B-lines at follow-up ultrasound from baseline(Day 0, Day 4 to 6)
  • Post-discharge readmission and mortality at 30 days(Day 30 post-discharge)
  • Post-discharge readmission and mortality at 60 days(Day 60 post-discharge)
  • Post-discharge readmission and mortality at 90 days(Day 90 post-discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Antonio Leidi

Principal Investigator

University Hospital, Geneva

研究点 (1)

Loading locations...

相似试验